{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T19:33:37Z","timestamp":1790969617621,"version":"4.1.0"},"reference-count":37,"publisher":"Jaypee Brothers Medical Publishing","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.4103\/0972-5229.83006","type":"journal-article","created":{"date-parts":[[2011,7,16]],"date-time":"2011-07-16T07:03:39Z","timestamp":1310799819000},"page":"71-77","source":"Crossref","is-referenced-by-count":20,"title":["Vasopressin: Its current role in anesthetic practice"],"prefix":"10.5005","volume":"15","author":[{"given":"Saikat","family":"Sengupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayeeta","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayanta K.","family":"Mitra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2914","published-online":{"date-parts":[[2011]]},"reference":[{"key":"ref=1","doi-asserted-by":"crossref","unstructured":"1. Mentzelopoulos SD, Zakynthinos SG, Tzoufi M, Katsios N, Papastylianou A, Gkisioti S, et al. Vasopressin, epinephrine, and corticosteroids for in-hospital cardiac arrest. Arch Intern Med 2009;169:15-24.","DOI":"10.1001\/archinternmed.2008.509"},{"key":"ref=2","doi-asserted-by":"crossref","unstructured":"2. Kam PC, Williams S, Yoong FF. Vasopressin and terlipressin: Pharmacology and its clinical relevance. Anaesthesia 2004;59:993-1001.","DOI":"10.1111\/j.1365-2044.2004.03877.x"},{"key":"ref=3","doi-asserted-by":"crossref","unstructured":"3. Schrier RW, Berl T, Anderson RJ. Osmotic and nonosmotic control of vasopressin release. Am J Physiol 1979;236:F321-32.","DOI":"10.1152\/ajprenal.1979.236.4.F321"},{"key":"ref=4","doi-asserted-by":"crossref","unstructured":"4. Kaufmann JE, Vischer UM. Cellular mechanisms of the hemostatic effects of desmopressin (DDAVP). J Thromb Haemost 2003;1:682-9.","DOI":"10.1046\/j.1538-7836.2003.00190.x"},{"key":"ref=5","doi-asserted-by":"crossref","unstructured":"5. D\u00fcnser MW, Mayr AJ, Ulmer H, Knotzer H, Sumann G, Pajk W, et al. Arginine vasopressin in advanced vasodilatory shock: A prospective randomised study. Circulation 2003;107:2313-9.","DOI":"10.1161\/01.CIR.0000066692.71008.BB"},{"key":"ref=6","doi-asserted-by":"crossref","unstructured":"6. Russell JA, Walley KR, Singer J, Gordon AC, H\u00e9bert PC, Cooper DJ, et al. Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med 2008;358:877-87.","DOI":"10.1056\/NEJMoa067373"},{"key":"ref=7","doi-asserted-by":"crossref","unstructured":"7. Robin JK, Oliver JA, Landry DW. Vasopressin deficiency in the syndrome of irreversible shock. J Trauma 2003;54:149-54.","DOI":"10.1097\/01.TA.0000064523.93060.60"},{"key":"ref=8","doi-asserted-by":"crossref","unstructured":"8. Sharshar T, Blanchard A, Paillard M, Raphael JC, Gajdos P, Annane D. Circulating vasopressin levels in septic shock. Crit Care Med 2003;31:1752-8.","DOI":"10.1097\/01.CCM.0000063046.82359.4A"},{"key":"ref=9","doi-asserted-by":"crossref","unstructured":"9. D\u00fcnser MW, Hasibeder WR, Wenzel V, Schwarz S, Ulmer H, Knotzer H, et al. Endocrinologic response to vasopressin infusion in advanced vasodilatory shock. Crit Care Med 2004;32:1266-71.","DOI":"10.1097\/01.CCM.0000127264.54807.B7"},{"key":"ref=10","doi-asserted-by":"crossref","unstructured":"10. Landry DW, Levin HR, Gallant EM, Ashton RC, Jr, Seo S, D\u2032Alessandro D, et al. Vasopressin deficiency contributes to the vasodilatation of septic shock. Circulation 1997;95:1122-5.","DOI":"10.1161\/01.CIR.95.5.1122"},{"key":"ref=11","doi-asserted-by":"crossref","unstructured":"11. Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J, et al. Surviving Sepsis Campaign Management Guidelines Comittee: Surviving sepsis campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 2004;32:858-73.","DOI":"10.1097\/01.CCM.0000117317.18092.E4"},{"key":"ref=12","doi-asserted-by":"crossref","unstructured":"12. Morales D, Madigan J, Cullinane S, Chen J, Heath M, Oz M, et al. Reversal of vasopressin of intractable hypotension in the late phase of haemorrhagic shock. Circulation 1999;100:226-9.","DOI":"10.1161\/01.CIR.100.3.226"},{"key":"ref=13","doi-asserted-by":"crossref","unstructured":"13. Albright TN, Zimmerman MA, Selzman CH. Vasopressin in the cardiac surgery intensive care unit. Am J Crit Care 2002;11:326-32.","DOI":"10.4037\/ajcc2002.11.4.326"},{"key":"ref=14","doi-asserted-by":"crossref","unstructured":"14. D\u00fcnser MW, Mayr AJ, Stallinger A, Ulmer H, Ritsch N, Knotzer H, et al. Cardiac performance during vasopressin infusion in postcardiotomy shock. Intensive Care Med 2002;28:746-51.","DOI":"10.1007\/s00134-002-1265-y"},{"key":"ref=15","doi-asserted-by":"crossref","unstructured":"15. Kill C, Wranze E, Wulf H. Sucessful treatment of severe anaphylactic shock with vasopressin. Int Arch Allergy Immunol 2004;134:260-1.","DOI":"10.1159\/000078775"},{"key":"ref=16","doi-asserted-by":"crossref","unstructured":"16. Tsuda A, Tanaka KA, Huraux C, Szlam F, Sato N, Yamaguchi K, et al. The in vitro reversal of histamine-induced vasodilatation in the human internal mammary artery. Anaesth Analg 2001;93:1453-9.","DOI":"10.1097\/00000539-200112000-00020"},{"key":"ref=17","doi-asserted-by":"crossref","unstructured":"17. De Kock M, Laterre PF, Andruetto P, Vanderessen L, Dekrom S, Vanderick B, et al. Ornipressin (Por 8): An efficient alternative to counteract hypotension during combined general\/epidural anaesthesia. Anesth Analg 2000;90:1301-7.","DOI":"10.1097\/00000539-200006000-00008"},{"key":"ref=18","doi-asserted-by":"crossref","unstructured":"18. Yeh CC, Wu CT, Lu CH, Yang CP, Wong CS. Early use of small dose vasopressin for unstable haemodynamics in an acute brain injury patient refractory to catecholamine treatment: A case report. Anesth Analg 2003;97:577-9.","DOI":"10.1213\/01.ANE.0000070231.16378.A6"},{"key":"ref=19","doi-asserted-by":"crossref","unstructured":"19. Bradley PG, Allen EK, Menon DK. Terlipressin for cerebral perfusion pressure support in a patient with septic shock. Anaesthesia 2004;59:619-20.","DOI":"10.1111\/j.1365-2044.2004.03816.x"},{"key":"ref=20","doi-asserted-by":"crossref","unstructured":"20. Jochberger S, Wenzel V, D\u00fcnser MW. Arginine vasopressin as a rescue vasopressor agent in the operating room. Curr Opin Anaesthesiol 2005;18:396-404.","DOI":"10.1097\/01.aco.0000174963.35877.81"},{"key":"ref=21","doi-asserted-by":"crossref","unstructured":"21. Chen JM, Cullinane S, Spanier TB, Artrip JH, John R, Edwards NM, et al. Vasopressin deficiency and pressor hypersensitivity in hemodynamically unstable organ donors. Circulation 1999;100:244-6.","DOI":"10.1161\/01.CIR.100.suppl_2.II-244"},{"key":"ref=22","unstructured":"22. Chernow B, Roth BL. Pharmacologic manipulation of the peripheral vasculature in shock: Clinical and experimental approaches. Circ Shock 1986;18:141-55."},{"key":"ref=23","doi-asserted-by":"crossref","unstructured":"23. Augoustides JG, Abrams M, Berkowitz D, Fraker D. Vasopressin for hemodynamic rescue in catecholamine-resistant vasoplegic shock after resection of massive pheochromocytoma. Anesthesiology 2004;101:1022-4.","DOI":"10.1097\/00000542-200410000-00031"},{"key":"ref=24","doi-asserted-by":"crossref","unstructured":"24. Veall GR, Peacock JE, Bax ND, Reilly CS. Review of the anaesthetic management of 21 patients undergoing laparotomy for carcinoid syndrome. Br J Anaesth1994;72:335-41.","DOI":"10.1093\/bja\/72.3.335"},{"key":"ref=25","doi-asserted-by":"crossref","unstructured":"25. Patel BM, Chittock DR, Russell JA, Walley KR. Beneficial effects of short-term vasopressin infusion during severe septic shock. Anesthesiology 2002;96:576-82.","DOI":"10.1097\/00000542-200203000-00011"},{"key":"ref=26","doi-asserted-by":"crossref","unstructured":"26. Wenzel V, Krismer AC, Arntz HR, Sitter H, Stadlbauer KH, Lindner KH. A comparison of vasopressin and epinephrine for out-of-hospital cardiopulmonary resuscitation. N Engl J Med 2004;350:105-13.","DOI":"10.1056\/NEJMoa025431"},{"key":"ref=27","doi-asserted-by":"crossref","unstructured":"27. Mukoyama T, Kinoshita K, Nagao K, Tanjoh K. Reduced effectiveness of vasopressin in repeated doses for patients undergoing prolonged cardiopulmonary resuscitation. Resuscitation 2009;80:755-61.","DOI":"10.1016\/j.resuscitation.2009.04.005"},{"key":"ref=28","doi-asserted-by":"crossref","unstructured":"28. Ioannou G, Doust J, Rockey DC. Terlipressin for acute esophageal variceal hemorrhage. Cochrane Database Syst Rev 2003;1:CD002147.","DOI":"10.1002\/14651858.CD002147"},{"key":"ref=29","doi-asserted-by":"crossref","unstructured":"29. Ozg\u00f6nenel B, Rajpurkar M, Lusher JM. How do you treat bleeding disorders with desmopressin? Postgrad Med J 2007;83:159-63.","DOI":"10.1136\/pgmj.2006.052118"},{"key":"ref=30","doi-asserted-by":"crossref","unstructured":"30. Toumba M, Stanhope R. Morbidity and mortality associated with vasopressin analogue treatment. J Pediatr Endocrinol Metab 2006;19:197-201.","DOI":"10.1515\/JPEM.2006.19.3.197"},{"key":"ref=31","doi-asserted-by":"crossref","unstructured":"31. Kahn JM, Kress JP, Hall JB. Skin necrosis after extravasation of low-dose vasopressin administered for septic shock. Criti Care Med 2002;30:1899-901.","DOI":"10.1097\/00003246-200208000-00038"},{"key":"ref=32","doi-asserted-by":"crossref","unstructured":"32. Stiell IG, H\u00e9bert PC, Wells GA, Vandemheen KL, Tang AS, Higginson LA, et al. Vasopressin versus epinephrine for inhospital cardiac arrest: A randomised controlled trial. Lancet 2001;358:105-9.","DOI":"10.1016\/S0140-6736(01)05328-4"},{"key":"ref=33","doi-asserted-by":"crossref","unstructured":"33. Morris DC, Dereczyk BE, Grzybowski M, Martin GB, Rivers EP, Wortsman J, et al. Vasopressin can increase coronary perfusion pressure during human cardiopulmonary resuscitation. Acad Emerg Med 1997;4:878-83.","DOI":"10.1111\/j.1553-2712.1997.tb03813.x"},{"key":"ref=34","doi-asserted-by":"crossref","unstructured":"34. Lindner KH, Prengel AW, Brinkmann A, Strohmenger HU, Lindner IM, Lurie KG. Vasopressin administration in refractory cardiac arrest. Ann Intern Med 1996;124:1061-4.","DOI":"10.7326\/0003-4819-124-12-199606150-00006"},{"key":"ref=35","doi-asserted-by":"crossref","unstructured":"35. Grmec S, Kamenik B and Mally S.Vasopressin in refractory out-of-hospital ventricular fibrillation: Preliminary results. Crit Care 2002;6:P162.","DOI":"10.1186\/cc1621"},{"key":"ref=36","doi-asserted-by":"crossref","unstructured":"36. Sharshar T, Annane D. Endocrine effects of vasopressin in critically ill patients. Best Pract Res Clin Anaesthesiol 2008;22:265-73.","DOI":"10.1016\/j.bpa.2008.02.005"},{"key":"ref=37","doi-asserted-by":"crossref","unstructured":"37. Lin IY, Ma HP, Lin AC, Chong CF, Lin CM, Wang TL. Low plasma vasopressin\/norepinephrine ratio predicts septic shock. Am J Emerg Med 2005;23:718-24.","DOI":"10.1016\/j.ajem.2005.02.055"}],"container-title":["Indian Journal of Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ijccm.org\/doi\/pdf\/10.4103\/0972-5229.83006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T19:40:17Z","timestamp":1712605217000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ijccm.org\/doi\/10.4103\/0972-5229.83006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011]]},"references-count":37,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2011]]}},"alternative-id":["10.4103\/0972-5229.83006"],"URL":"https:\/\/doi.org\/10.4103\/0972-5229.83006","relation":{},"ISSN":["0972-5229","1998-359X"],"issn-type":[{"value":"0972-5229","type":"print"},{"value":"1998-359X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011]]}}}